Sensitivities of major causative organisms isolated from patients with acute uncomplicated cystitis against variousantibacterial agents: Results of subanalysis based on the presence of menopause

Journal of Infection and Chemotherapy

Volumn 18, Issue 4, 2012, Pages 597-607

  Matsumoto, Tetsuro ^a   Hamasuna, Ryoichi ^a   Ishikawa, Kiyohito ^b   Takahashi, Satoshi ^c   Yasuda, Mitsuru ^d   Hayami, Hiroshi ^e   Tanaka, Kazushi ^f   Muratani, Tetsuro ^g   Monden, Koichi ^h,k   Arakawa, Soichi ⁱ   Yamamoto, Shingo ^j  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Kyurin Medical Laboratory   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ KOBE UNIVERSITY HOSPITAL   (Japan)

^j HYOGO COLLEGE OF MEDICINE   (Japan)

^k Araki Urological Clinic   (Japan)

more..

Author keywords

Acute uncomplicated cystitis; Bacterial sensitivity; Escherichia coli; Quinolone resistance; Urinary tract infection

Indexed keywords

ANTIINFECTIVE AGENT; CEFCAPENE PIVOXIL; CEFDINIR; CEPHEM DERIVATIVE; CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; TOSUFLOXACIN;

ACUTE UNCOMPLICATED CYSTITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; CYSTITIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; JAPAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MENOPAUSE; MINIMUM INHIBITORY CONCENTRATION; POSTMENOPAUSE; PREMENOPAUSE; REVIEW; RISK FACTOR; STREPTOCOCCUS AGALACTIAE;

EID: 84865113050     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0419-2     Document Type: Article

References (21)

1. K Yamaguchi A Ohno Levofloxacin Surveillance Group 2005 Investigation of the susceptibility trends in Japan tofluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from1994 to 2002 Diagn Microbiol Infect Dis 52 135 143 15964502 10.1016/j.diagmicrobio.2005.02.009 1:CAS:528:DC%2BD2MXlt1Whs7o%3D(Pubitemid 40826940)
2. Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, et al. Comparative studies on activities ofantimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004): I.Susceptibility distribution. Jpn J Antibiot. 2006;59:177-200 (in Japanese). (Pubitemid 44098196)
3. K Yamaguchi N Furuya M Iwata N Watanabe N Uehara M Yasujima, et al. 2005 Surveillance of susceptibility of clinicalisolates to gatifloxacin and various antimicrobial agents Jpn J Chemother 53 627 640 (Pubitemid 41723554)
4. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Kanda M, et al. In vitro susceptibilities to levofloxacin and variousantibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004. Jpn J Antibiot. 2006;59:428-51 (inJapanese). (Pubitemid 46212601)
5. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Kanda M, et al. In vitro susceptibilities to levofloxacin and variousantibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007. Jpn J Antibiot. 2009;62:346-70 (inJapanese).
6. Committee on Revision of UTI Drug Efficacy Evaluation Standards, Japanese Society of Chemotherapy. Guidelines forclinical trials on genitourinary tract infections, version 1. Jpn J Chemother. 2009;57:511-25.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing;Seventeenth Informational Supplement M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007.
8. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria ThatGrow Aerobically; Approved Standard-Seventh Edition, M 7-A 7. Wayne: Clinical and Laboratory Standards Institute; 2006.
9. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing ofInfrequently Isolated or Fastidious bacteria; Approved Guideline, M45-A. Wayne: Clinical and Laboratory Standards Institute;2006.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing;eighteenth informational supplement. Document M100-S18. Wayne: CLSI; 2008.
11. C Nakahama 2009 Acute uncomplicated cystitis Sougou Rinsyo 58 1415 1420
12. T Matsumoto 2008 Infections at the department of urology Chiryo 90 11 2868 2872
13. T Ishii K Kawamura K Aihara K Tokunaga K Suzuki 2004 Activities of antimicrobial agents against causative organismsisolated from patients with urinary tract infections Kanazawa Ika Daigaku Zasshi 29 227 234 1:CAS:528:DC%2BD2MXksVymtr8%3D
14. S Ishihara T Deguchi I Shinoda S Nezasa H Komeda S Hayashi, et al. 2003 Efficacy and safety of cefdinir against acuteuncomplicated cystitis Jpn J Chemother 51 750 757 (Pubitemid 38128800)
15. M Yasuda 2008 Antimicrobial agents for urinary tract infections Intern Med 102 878 883
16. T Muratani 2009 Resistance of bacteria isolated from urinary tract infections to antimicrobial agents and approach topreventing resistance Antibiot Chemother 25 29 39
17. KG Naber G Schito H Botto J Palou T Mazzei 2008 Surveillance study in Europe and Brazil on clinical aspects andantimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy Eur Urol 54 11641178 18511178 10.1016/j.eururo.2008.05.010
18. H Kanda Y Kurosaka K Fujikawa M Chiba S Yamachika R Okumura, et al. 2008 In vitro and in vivo antibacterial activityof sitafloxacin Jpn J Chemother 56 1 17 1:CAS:528:DC%2BD1cXlvVWrtL4%3D (Pubitemid 351662837)
19. M Kouda H Matsushima J Hashiguchi T Takahashi 2009 Investigation of fluoroquinolone resistant Escherichia coliisolated from urine Jpn J Urol Surg 22 71 77
20. H Arslan OK Azap O Ergönül Urinary Tract Infection Study Group 2005 Risk factors for ciprofloxacinresistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J AntimicrobChemother 56 914 918 16174685 10.1093/jac/dki344 1:CAS:528: DC%2BD2MXhtFCjtLbJ (Pubitemid 41631917)
21. T Matsumoto R Hanasuna K Ishikawa S Takahashi M Yasuda H Hayami, et al. 2011 Nationwide survey of antibacterialactivity against clinical isolates from urinary tract infections in Japan (2008) Int J Antimicrob Agents 37 210 218 2124206210.1016/j.ijantimicag.2010.10.032 1:CAS:528:DC%2BC3MXit12hsrs%3D